Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02890758
Title Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors David Wald
Indications

sarcoma

non-Hodgkin lymphoma

myelodysplastic syndrome

acute myeloid leukemia

acute lymphoblastic leukemia

multiple myeloma

chronic myeloid leukemia

rectum cancer

Ewing sarcoma

rhabdomyosarcoma

chronic lymphocytic leukemia

colon carcinoma

myeloproliferative neoplasm

Hodgkin's lymphoma

Therapies

ALT-803

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.